How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

3,707 results for

Congenital Heart Disease Imaging in Adults

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

81. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society

patients in this document is intended to direct healthcare providers to exercise clinical judgment, which is often required during the evaluation and management of patients with syncope. When a recommendation is made to refer a patient to a specialist with expertise for further evaluation, such as in the case of autonomic neurology, adult congenital heart disease (ACHD), older populations, or athletes, the writing committee agreed to make Class IIa recommendations because of the paucity of outcome data (...) , structural heart disease, previous arrhythmias, or reduced ventricular function Brief prodrome, such as palpitations, or sudden loss of consciousness without prodrome Syncope during exertion Syncope in the supine position Low number of syncope episodes (1 or 2) Abnormal cardiac examination Family history of inheritable conditions or premature SCD (<50 y of age) Presence of known congenital heart disease More Often Associated with Noncardiac Causes of Syncope Younger age No known cardiac disease Syncope

2017 American Heart Association

82. Normal values for myocardial deformation within the right heart measured by feature-tracking cardiovascular magnetic resonance imaging. (PubMed)

Normal values for myocardial deformation within the right heart measured by feature-tracking cardiovascular magnetic resonance imaging. Reproducible and repeatable assessment of right heart function is vital for monitoring congenital and acquired heart disease. There is increasing evidence for the additional value of myocardial deformation (strain and strain rate) in determining prognosis. This study aims to determine the reproducibility of deformation analyses in the right heart using (...) cardiovascular magnetic resonance feature tracking (FT-CMR); and to establish normal ranges within an adult population.A cohort of 100 healthy subjects containing 10 males and 10 females from each decade of life between the ages of 20 and 70 without known congenital or acquired cardiovascular disease, hypertension, diabetes, dyslipidaemia or renal, hepatic, haematologic and systemic inflammatory disorders underwent FT-CMR assessment of right ventricular (RV) and right atrial (RA) myocardial strain and strain

Full Text available with Trip Pro

2017 International journal of cardiology

83. Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires

Intervention/treatment Phase Pulmonary Artery Hypertension Congenital Heart Disease Structural Heart Disease Procedure: MRI Right Heart guidewire catheterization Phase 1 Phase 2 Detailed Description: Heart catheterization is a minimally invasive procedure to measure pressure into specific heart cavities. Heart catheterization usually uses X-ray guidance, which involves radiation exposure, and which fails to visualize soft tissue. For several years, real-time magnetic resonance imaging (MRI) fluoroscopy has (...) Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires Right Heart Catheterization Using Magnetic Resonance Imaging Fluoroscopy and Passive Guidewires - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one

2017 Clinical Trials

84. Interventional cardiology in adults with congenital heart disease. (PubMed)

Interventional cardiology in adults with congenital heart disease. Interventional cardiac catheterization has become an integral component of the management of adults with congenital heart disease. The origins of this approach come from the paediatric interventional experience, although techniques and indications for interventional cardiac catheterization in adults are now being developed for use in the burgeoning field of adult congenital heart disease. Progress in the application (...) and acceptance of interventional cardiac catheterization in this setting has been swift, and the pace is quickening. This Review provides a broad overview of some of the most common procedures used in the treatment of adults with congenital heart lesions, with an emphasis on new tools that have revolutionized the field. Specifically, we discuss interventions that can be broadly classified into the following groups: techniques for closing shunt lesions, valvular interventions, methods for achieving patency

2013 Nature reviews. Cardiology

85. ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease

ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. ST2, a Novel Biomarker for Cardiac Remodeling in Adults With Congenital Heart Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01774890 Recruitment Status : Completed First Posted : January 24, 2013 Last Update Posted : August 10, 2017 Sponsor: Hadassah Medical Organization

2013 Clinical Trials

86. Magnetic Resonance Myocardial Perfusion Imaging: Safety and Indications in Pediatrics and Young Adults. (PubMed)

, exercise-induced stress MPI, and MPI for cardiac mass diagnosis. Relevant clinical history, exam indications, and adverse reactions following gadolinium-based contrast agent and adenosine administration were recorded. Studies were reviewed for the presence of myocardial perfusion defects, wall motion abnormalities, and delayed myocardial enhancement. The most common indications from MPI were congenital heart disease (CHD), Kawasaki disease, anomalous coronary artery, or myocardial mass characterization (...) Magnetic Resonance Myocardial Perfusion Imaging: Safety and Indications in Pediatrics and Young Adults. The purpose of this study was to assess the safety and indications for cardiac magnetic resonance (CMR) with myocardial perfusion imaging (MPI) in a cohort of children and young adults. A retrospective review of 178 children and young adults who underwent CMR with MPI was performed. Studies were categorized based on study protocols as MPI with resting perfusion only, adenosine stress MPI

2017 Pediatric Cardiology

87. Effects of High-intensity Interval Training on Exercise Capacity in Patients With Grown-up Congenital Heart Disease

markers for heart failure as well as occurrence of irregular fast heart beats will be assessed. Condition or disease Intervention/treatment Phase Congenital Heart Defects Procedure: HIIT Other: MICE Not Applicable Detailed Description: Background Adults with congenital heart disease have long been recommended to refrain from physical exercise. Therefore, they often have significant reduction in exercise capacity. Only recently, regular exercise has been shown to be safe and is nowadays recommended (...) and important exercise modality in cardiac rehabilitation centers all over Europe for stable cardiac patients with left ventricular (LV) dysfunction. However, its safety and efficacy has not yet been tested in adults with congenital heart disease and to date there are no studies who have evaluated whether short term peaks of pulmonary artery or systemic pressure during bouts of 4 min of high-intensity exercise negatively affects the subpulmonary or systemic ventricle in GUCH patients. The investigators

2015 Clinical Trials

88. NOACs for Atrial Tachyarrhythmias in Congenital Heart Disease

Posted : October 10, 2016 Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Collaborator: The Interuniversity Cardiology Institute of the Netherlands Information provided by (Responsible Party): Berto J Bouma, Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) Study Details Study Description Go to Brief Summary: Rationale: Adult patients with congenital heart disease (CHD) with atrial tachyarrhythmias need to be anticoagulated. It is not known whether non (...) -vitamin K antagonist oral anticoagulants (NOAC) in this patient group are efficient and safe. Aim: The purpose of the NOTE registry is to evaluate the efficacy and safety of NOACs for thromboembolic prevention in atrial tachyarrhythmias in adult patients with congenital heart disease (CHD). Methods: In this multicenter prospective registry adult CHD patients with atrial tachyarrhythmias on NOACs (switch from VKA or new on anticoagulants) will be followed for a minimum of two years. Primary efficacy

2015 Clinical Trials

89. Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease

. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Layout table for eligibility information Ages Eligible for Study: up to 18 Years (Child, Adult) Sexes Eligible for Study: All Accepts Healthy Volunteers: No Sampling Method: Non-Probability Sample Study Population Children with cyanotic congenital heart disease (...) Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease Near Infrared Spectroscopy in Cyanotic Congenital Heart Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Near Infrared Spectroscopy

2015 Clinical Trials

90. Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures in Patients With Congenital Heart Disease: 15-Year Data From a Population-Based Longitudinal Cohort. (PubMed)

Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures in Patients With Congenital Heart Disease: 15-Year Data From a Population-Based Longitudinal Cohort. The burden of low-dose ionizing radiation (LDIR) exposure from medical procedures among individuals with congenital heart disease (CHD) is unknown. In this longitudinal population-based study, we sought to determine exposure to LDIR-related cardiac imaging and therapeutic procedures in children and adults with CHD.In an analysis (...) of the Quebec CHD database, exposure to the following LDIR-related cardiac procedures was recorded: catheter-based diagnostic procedures, structural heart interventions, coronary interventions, computed tomography scans of the chest, nuclear procedures, and pacemaker/implantable cardioverter-defibrillator insertion and repair. From 1990 to 2005, there were 16 253 LDIR-exposed patients with CHD with 317 988 patient-years of available follow-up. The total number of LDIR-related procedures increased from 18.5

Full Text available with Trip Pro

2015 Circulation

91. T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease

T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease T1 Mapping of Diffuse Myocardial Fibrosis in Congenital Heart Disease - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. T1 Mapping (...) of Diffuse Myocardial Fibrosis in Congenital Heart Disease The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02350829 Recruitment Status : Unknown Verified April 2015 by Lars Grosse-Wortmann, The Hospital for Sick Children. Recruitment status was: Recruiting First Posted : January 30, 2015 Last Update

2015 Clinical Trials

92. Cardiovascular management in pregnancy: congenital heart disease. (PubMed)

Cardiovascular management in pregnancy: congenital heart disease. The population of adults with CHD continues to expand,and thus the number of women with CHD who contemplate pregnancy or become pregnant is also growing. Mothers with low-risk defects can be managed by general cardiologist,whereas those with more complex defects should be managed by or with the assistance of ACHD cardiologists. It is important to acknowledge that all patients with CHD may have unique anatomy or physiology (...) , despite their classification as having a simple, moderate, or complex defect. As such, clinicians evaluating these patients should have adequate knowledge and expertise when assessing patient's risk for pregnancy,when performing imaging or hemodynamic studies, and when managing these patients during pregnancy. The American Board of Medical Specialties has recently recognized ACHD as a subspecialty of cardiovascular disease to treat the specialized needs of these patients in adulthood. ACHD experts can

Full Text available with Trip Pro

2014 Circulation

93. White Matter Microstructure and Cognition in Adolescents with Congenital Heart Disease. (PubMed)

White Matter Microstructure and Cognition in Adolescents with Congenital Heart Disease. To describe the relationship between altered white matter microstructure and neurodevelopment in children with dextro-transposition of the great arteries (d-TGA).We report correlations between regional white matter microstructure as measured by fractional anisotropy (FA) and cognitive outcome in a homogeneous group of adolescents with d-TGA. Subjects with d-TGA (n = 49) and controls (n = 29) underwent (...) diffusion tensor imaging and neurocognitive testing. In the group with d-TGA, we correlated neurocognitive scores with FA in 14 composite regions of interest in which subjects with d-TGA had lower FA than controls.Among the patients with d-TGA, mathematics achievement correlated with left parietal FA (r = 0.39; P = .006), inattention/hyperactivity symptoms correlated with right precentral FA (r = -0.39; P = .006) and left parietal FA (r = -0.30; P = .04), executive function correlated with right

Full Text available with Trip Pro

2014 Journal of Pediatrics

94. NICOM in Pregnant Women With Heart Disease

using the NICOM against echocardiography for use in structurally normal and abnormal pregnant hearts in order to better drive goal-directed (specifically delivery mode) therapy through continuous hemodynamic monitoring during the second and third stages of labor, and 24 hours postpartum. Condition or disease Intervention/treatment Heart Diseases in Pregnancy Congenital Heart Disease in Pregnancy Diagnostic Test: NICOM (non-invasive cardiac output monitor) Study Design Go to Layout table for study (...) Years and older (Adult, Older Adult) Sexes Eligible for Study: Female Gender Based Eligibility: Yes Gender Eligibility Description: pregnant women. Accepts Healthy Volunteers: Yes Sampling Method: Non-Probability Sample Study Population Both healthy pregnant women and pregnant women with a history of heart disease will be recruited to participate in our observational, non-inferiority trial comparing the cardiac output measurements obtained by two different modalities. Women in their first trimester

2018 Clinical Trials

95. Oncologic imaging

Health. All Rights Reserved. 3 Pancreatic Cancer 72 Paraneoplastic Syndrome 74 Penile, Vaginal, and Vulvar Cancers 75 Prostate Cancer 77 Sarcoma of Bone and Soft Tissue 80 Thoracic Cancers – Pleura, Thymus, Heart and Mediastinum 83 Thyroid Cancer 85 Uterine Cancer 88 Codes 91 History 93 Oncologic Imaging Copyright © 2019. AIM Specialty Health. All Rights Reserved. 4 Description and Application of the Guidelines The AIM Clinical Appropriateness Guidelines (hereinafter “the AIM Clinical Appropriateness (...) gastrointestinal indications or congenital spinal anomalies Repeated Imaging In general, repeated imaging of the same anatomic area should be limited to evaluation following an intervention, or when there is a change in clinical status such that imaging is required to determine next steps in management. At times, repeated imaging done with different techniques or contrast regimens may be necessary to clarify a finding seen on the original study. Repeated imaging of the same anatomic area (with same or similar

2019 AIM Specialty Health

96. Vascular imaging

– intracranial 14 Vertebrobasilar aneurysm or dissection 15 Vertebrobasilar stenosis or occlusion 15 Chest 15 Vascular Imaging Copyright © 2019. AIM Specialty Health. All Rights Reserved. 3 Aortic aneurysm or dissection 15 Atheromatous disease (Adult only) 16 Pulmonary embolism 16 Other vascular indications – chest 18 Abdomen and Pelvis 18 Aneurysm of the abdominal aorta 18 Aneurysm of the iliac vessels 19 Arteriovenous malformation or fistula 20 Dissection of the abdominal aorta or branch vessel 20 Hematoma (...) or MRA neck Vertebrobasilar stenosis or occlusion Advanced imaging is considered medically necessary for evaluation when the results of imaging will impact management. IMAGING STUDY - CTA or MRA neck Chest Aortic aneurysm or dissection Advanced imaging is considered medically necessary in ANY of the following scenarios: ADULT ? Suspected aortic aneurysm or dissection ? Evaluation for disease progression based on signs or symptoms ? Preoperative planning for aneurysm or dissection repair ? Following

2019 AIM Specialty Health

97. Chest imaging

effectively evaluate the most common causes of recurrent focal airspace disease, including foreign bodies, mucous plugging, and other intraluminal obstructions. However, practice consensus is that CT may be indicated when bronchoscopy is inconclusive. Recurrent pneumonia in the same area is likely due to underlying structural disease—primarily right middle lobe syndrome (airway disease of uncertain pathophysiology) (61%) and congenital lung malformations (21%); diagnostic imaging involving bronchoscopy (...) Imaging of the Chest Copyright © 2019. AIM Specialty Health. All Rights Reserved. 14 Parenchymal Lung Disease – not otherwise specified Asbestos-related lesions involving the lungs and pleura (Adult only) Advanced imaging is considered medically necessary for diagnosis and management when the results of imaging will impact treatment decisions. Note: Asbestos exposure may also manifest in nonmalignant pulmonary conditions including interstitial lung disease, pleural effusion, or pleural plaques

2019 AIM Specialty Health

98. Appropriate Use Criteria: Imaging of the Brain

under 5 months of age Rationale Congenital anomalies of the central nervous system can be classified 2 into disorders of dorsal/ventral induction such as myelomeningocele, holoprosencephaly, Dandy-Walker variant, or craniosynostosis, disorders of neural proliferation such as microcephaly and megalencephaly, disorders of neuronal migration such as schizencephaly and cortical heterotopias, and disorders of myelination such as adrenoleukodystrophy and Canavan disease. There are characteristic imaging (...) sensitive than ultrasound and is usually the primary modality of choice when indicated to direct management. 49 Dementia (Adult only) Advanced imaging is considered medically necessary in EITHER of the following scenarios: ? Initial evaluation to exclude a secondary cause of symptoms ? Evaluation of rapidly progressive symptoms IMAGING STUDY - MRI brain - CT brain (when MRI contraindicated) A one-time FDG-PET scan for differentiating between frontotemporal dementia and Alzheimer’s disease is considered

2019 AIM Specialty Health

99. ACR–ASNR–SPR Practice Parameter for the Performance and Interpretation of Magnetic Resonance Imaging (MRI) of the Brain

. Vascular a. Acute ischemia and infarction [9-13]. b. Chronic vascular disease [14-16]. c. Vascular malformations such as developmental venous anomaly, cavernous angioma, arteriovenous malformation, arteriovenous fistulas and aneurysm [17-20]. d. Arterial or venous/dural venous sinus abnormalities, including congenital and acquired disorders and thrombosis [21,22]. e. Additionally, magnetic resonance angiography (MRA) may provide more detailed noninvasive vascular information. (See the ACR–ASNR–SNIS–SPR (...) ). (Alternatively one postcontrast series could be obtained using a T1-weighted volumetric acquisition). Postcontrast FLAIR images may add value in the assessment of leptomenigeal disease [113]. With the advent of high-performance gradient coil assemblies and amplifiers and other technical enhancements, advanced imaging applications are also an option when the appropriate hardware and software exist. Improvements in the receiver and data acquisition systems also allow for more rapid imaging. Higher-field

2019 American Society of Neuroradiology

100. Society of Interventional Radiology Consensus Guidelines for the Periprocedural Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided Interventions—Part II: Recommendations.

management of anticoagulation in patients with nonvalvular atrial fibrillation: a report of the American College of Cardiology Clinical Expert Consensus Document Task Force. J Am Coll Cardiol . 2017 ; 69 : 871–898 , x 4 Raval, A.N., Cigarroa, J.E., Chung, M.K. et al. American Heart Association Clinical Pharmacology Subcommittee of the Acute Cardiac Care and General Cardiology Committee of the Council on Clinical Cardiology; Council on Cardiovascular Disease in the Young; and Council on Quality of Care (...) Kearon, C., Akl, E.A., Ornelas, J. et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest . 2016 ; 149 : 315–352 , x 9 Lip, G.Y.H., Banerjee, A., Boriani, G. et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest . 2018 ; 154 : 1121–1201 , x 10 Nishimura, R.A., Otto, C.M., Bonow, R.O. et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report

Full Text available with Trip Pro

2019 Society of Interventional Radiology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>